Norris Medicines Files 35th Annual Report for FY26

Norris Medicines Ltd has filed its 35th Annual Report for the financial year 2025-26, as per SEBI regulations. The report, sent electronically to shareholders, is also available on the company's website. It includes the Board's Report, Secretarial Audit Report, Management Discussion and Analysis, financial statements (Balance Sheet, Profit & Loss, Cashflow), and auditor's report. The Annual General Meeting (AGM) is scheduled for September 29, 2026, to adopt the audited financial statements for the year ended March 31, 2026, and to re-appoint Mr. Praveen J. Bafna as Director. Additionally, a special resolution will be considered for the appointment of Mr. Vimal D. Shah as Managing Director.